Diagnosis and treatment of malignant retroperitoneal mesothelioma: A case report.

Medicine (Baltimore)

Department of Urinary Surgery, Weifang People's Hospital, No.151 Guangwen Street, Weifang City, Shandong, China.

Published: April 2024

Rationale: Malignant peritoneal mesothelioma (MPM) is a rare clinical disease. Although there are several reports describing intraperitoneal mesothelioma of the lung, liver, and intestine, retroperitoneal mesothelioma is, to our knowledge, very rare and rarely reported. In recent years, our best clinical protocols for the treatment and diagnosis of retroperitoneal mesothelioma have not been proven and the diagnosis and treatment are challenging.

Patient Concerns: A 37-year-old Chinese woman complained of bilateral low back pain for a month, with obvious symptoms of low back pain on the left side. To treat low back pain, retroperitoneal masses were found during physical examination. The patient consulted a urological specialist for further treatment.

Diagnosis: After the operation, pathological biopsy confirmed retroperitoneal epithelioid diffuse mesothelioma.

Interventions: After exclusion of surgical contraindications, the patient underwent laparoscopic retroperitoneal lesion resection under tracheal intubation and general anesthesia, and the operation was successful.

Outcomes: On the tenth day after surgery, the patient vital signs were stable, and he was discharged.

Lessons: Patients with malignant peritoneal mesothelioma may have no typical clinical symptoms, and the diagnosis is based on pathological and immunohistochemical examination. In selected patients, surgical cell reduction and intraoperative intraperitoneal heat chemotherapy have become the first choice of treatment, which can achieve ideal therapeutic effects and prolong survival.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11049770PMC
http://dx.doi.org/10.1097/MD.0000000000037985DOI Listing

Publication Analysis

Top Keywords

retroperitoneal mesothelioma
12
low pain
12
diagnosis treatment
8
malignant peritoneal
8
peritoneal mesothelioma
8
retroperitoneal
6
mesothelioma
6
diagnosis
4
treatment malignant
4
malignant retroperitoneal
4

Similar Publications

Malignant adnexal tumor harboring a somatic mutation in a woman previously diagnosed with mesothelioma, a case report.

Gynecol Oncol Rep

December 2024

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Kentucky, Lexington, KY 40536, USA.

Article Synopsis
  • STK11 gene mutations are linked to Peutz-Jeghers syndrome, which increases the risk of various cancers, including gastrointestinal and breast cancers.
  • The article describes a rare case of an STK11-associated adnexal tumor in a 39-year-old woman who previously had malignant mesothelioma.
  • The need for careful diagnosis and further analysis of STK11 adnexal tumors is highlighted due to their uncommon occurrence and unclear pathology.
View Article and Find Full Text PDF

Mesothelioma of the testicular vagina is a rare malignant tumour, most often discovered by chance. The rarity of this type of tumour has not led to the development of specific guidelines. Median survival is estimated at 30 months.

View Article and Find Full Text PDF

Malignant mesothelioma of the tunica vaginalis testis (MMTVT) is a rare tumor of the testicular sheath. More than 50% of cases initially present as recurrent hydrocele, but there have also been documented cases with hematocele, inguinal hernia, or epididymitis. Due to the non-specific symptoms and signs of the disease, it is almost always diagnosed intra- or postoperatively.

View Article and Find Full Text PDF

Diagnosis and treatment of malignant retroperitoneal mesothelioma: A case report.

Medicine (Baltimore)

April 2024

Department of Urinary Surgery, Weifang People's Hospital, No.151 Guangwen Street, Weifang City, Shandong, China.

Rationale: Malignant peritoneal mesothelioma (MPM) is a rare clinical disease. Although there are several reports describing intraperitoneal mesothelioma of the lung, liver, and intestine, retroperitoneal mesothelioma is, to our knowledge, very rare and rarely reported. In recent years, our best clinical protocols for the treatment and diagnosis of retroperitoneal mesothelioma have not been proven and the diagnosis and treatment are challenging.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!